Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

There is also a lot of uncertainty around the prospects of an avian flu vaccine for humans. Several major companies that manufacture them have said they could expedite the production of millions ...

The Centers for Disease Control and Prevention (CDC) said the "U.S. government is developing vaccines against avian influenza A(H5N1) viruses in case they are needed." According to the CDC ...

The companies are developing experimental vaccines against pandemic influenza, including the avian H5N1 strain that has infected more than 60 people in the U.S. in the past year, mostly from ...

Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK (GSK) for H5N1 avian flu. Read more here.

Trump's pick of Robert F. Kennedy Jr. for Department of Health and Human Services secretary is a well-known vaccine skeptic.

Moderna (MRNA) shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.

Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...